Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Latest full-year results from official filings.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
Jan 2025: TA Associates secured about 94.95% of Nexus AG shares through its public takeover offer and said it intended to delist the company, taking it into private-equity ownership.
Data breaches, cyber incidents, regulator action and assurance status.
No cyber incidents, data breaches or regulator actions involving Nexus AG found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Recalls, safety notices, regulator action and clinical safety concerns.
No product recalls, safety notices or regulator actions involving Nexus AG found in HSH's search of the last 24 months.
Contract delivery, go-lives, terminations and disputes.
No contract disputes, terminations, troubled implementations or notable new contracts involving Nexus AG found in HSH's search of the last 24 months.